Notta Oral Drops, Bottle with Dropper, 50 ml

Composition and Dosage Form

Composition

Active ingredients: 100 ml of the product contains: Avena sativa D1 – 20 ml, Phosphorus D12 – 10 ml, Chamomilla D12 – 10 ml, Coffea D12 – 10 ml, Zincum valerianicum D12 – 10 ml.

Excipients: ethanol 43% (w/w).

1 ml of solution contains 25 drops.

Dosage Form

Oral drops.

Pharmacological Properties

Pharmacodynamics

Notta reduces anxiety, feelings of fear, irritability, nervous tension, and restlessness. It has a pronounced stress-protective effect.

It positively affects the course of neurovegetative disorders: reduces the frequency and intensity of headaches, dizziness, palpitations and cardiac rhythm disturbances, nausea, shortness of breath, sensation of a “lump” in the throat, chest pain and epigastric pain resulting from nervous overstrain.

Normalizes sleep: facilitates falling asleep, improves the quality of night sleep, reduces the number of nighttime awakenings; contributes to the restoration of physiological sleep and the sleep–wake cycle, without causing difficulties upon awakening or daytime drowsiness.

Reduces the severity of asthenia (lethargy, increased fatigue). Improves concentration, clarity of thinking, and memory.

Notta enhances the individual compensatory capabilities of the psyche, work capacity, and resistance to psycho-emotional stress.

Pharmacokinetics

Not studied.

Indications

As part of combination therapy for psychosomatic disorders and any conditions after nervous overstrain or stress accompanied by restlessness, anxiety, depression, sleep disorders, and nervous exhaustion.

In pediatrics: as part of combination therapy for the consequences of perinatal CNS damage, hypertensive liquorodynamic syndrome, neurogenic bladder syndrome, autonomic dysfunction syndrome, asthenic symptom complex of various etiologies, and increased neuro-reflex excitability syndrome.

Dosage and Administration

Notta oral drops

Adults and children over 12 years: 10 drops undiluted or diluted in 1 tablespoon of water.

Children aged 2–12 years: 5–7 drops diluted in 1 tablespoon of water.

Take 3 times daily, 30 minutes before or 1 hour after meals.

At the beginning of treatment, as well as in cases requiring rapid symptom relief, the product may be taken every 0.5–1 hour: adults and children over 12 years – 8–10 drops; children aged 2–12 years – 3–5 drops diluted in 1 tablespoon of water until improvement occurs, but no more than 8 times per day, after which continue taking 3 times daily.

To enhance effectiveness, it is recommended to keep the product in the mouth for a short time before swallowing.

The course of treatment, depending on the severity and duration of the condition, is 1–4 months. If necessary, the course may be repeated.

Children

Notta oral drops are prescribed for children from 2 years of age.

Special Warnings and Precautions

Notta does not cause inhibition, daytime drowsiness, impaired consciousness, or sexual dysfunction; therefore, it can be recommended for people of any profession, including those requiring increased attention and rapid motor and mental reactions.

At the beginning of treatment, a slight temporary increase in symptoms (primary reaction) may occur. This reaction is not harmful and does not require discontinuation. If symptoms do not disappear, the product should be discontinued. After resolution of the primary reaction, the product may be used again. In case of repeated exacerbation of symptoms, discontinue use.

Since Notta contains natural plant components, slight changes in taste, clarity, or color may occur during storage, which do not affect its effectiveness.

Notta tablets contain lactose; therefore, patients with rare hereditary galactose intolerance, lactase deficiency, or glucose-galactose malabsorption syndrome should use Notta in the form of drops instead of tablets.

Notta oral drops should not be used in patients with alcohol dependence, as one dose (5/10 drops) contains 80/160 mg of alcohol.

The alcohol content should also be considered during pregnancy, breastfeeding, in children, and in patients with a high risk of liver disease or epilepsy.

Long-term treatment with homeopathic medicines should be supervised by a homeopathic physician, as symptoms not listed in the instructions may occur.

Use During Pregnancy or Breastfeeding

Data on use during pregnancy and breastfeeding are lacking. To date, no information has been registered regarding any risk to the fetus or child from use during pregnancy or breastfeeding. Use during pregnancy and breastfeeding only if the expected benefit to the mother outweighs the potential risk to the fetus/child.

No data are available on the effect on reproductive function.

Effects on Ability to Drive

Despite the alcohol content, the product at recommended doses does not affect the ability to drive vehicles or operate machinery.

Contraindications

Hypersensitivity to any component of the product.

Adverse Reactions

Not detected. In exceptional cases, allergic reactions may occur in individuals with hypersensitivity to any component.

Overdose

No cases reported.

Drug Interactions

No clinically significant interactions between Notta and other medicinal products have been established. It may be combined with any medicines and treatment methods.

When used concomitantly with psychotropic medicines (including tranquilizers and hypnotics), doses of the latter may be reduced under medical supervision. In combination therapy, maintain an interval of at least 20 minutes between administrations.

Unhealthy lifestyle, use of stimulants, and poor nutrition may negatively affect the results of homeopathic treatment.

Storage Conditions

Store in a tightly closed bottle in the original carton at a temperature not exceeding 30 °C, out of reach of children.